|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessing the impact of arthropod natural enemies on crop pests at the field scale显示文摘有许多原因,我们发现方法保存,是重要的,并且更好利用无脊椎的庄稼害虫的生来的敌人。当前,生来的敌人影响的措施很少被合并到声称检验害虫控制的研究。大多数研究检验害虫和生来的敌人存在或丰富然后品质上推断影响。当这提供有用数据探讨生态的问题的一个范围时,影响的一项措施为指导害虫管理决策是批评的。经常,一些很简单的技术能被用来获得生来的敌人影响的估计。我们使用了笼子,限制生来的敌人或猎物运动的障碍,生来的敌人攻击的直接观察,和哨兵的基于地的研究的现在的例子估计的猎物项目死亡。在每研究使用的生来的敌人影响的措施需要被定制到农民和他们面对的特定的害虫问题的需要。例如,归因于生来的敌人的死亡的大小可能不比预定和在季节之间的那死亡的一致性重要。定制影响评价将导致简单地不提供怎么保存生来的敌人,但是怎么把这些生来的敌人用作决策的不可分的部分的一般信息的研究结果。 | Sarina Macfadyen Andrew P. Davies Myron P. Zalucki | 2015 | Insect Science2015，22，1： | 7 |
| 2 | Connecting scales: Achieving in-field pest control from areawide and landscape ecology studies显示文摘Areawide 管理有完成然而,在那里指向害虫的答案的长历史是节肢动物天赋敌人的 areawide 管理的小焦点。显示出在生来的敌人丰富和产地差异之间的一种积极关系的风景生态学研究表明风景依赖者害虫抑制,但是还没有清楚地连接了他们的调查结果到害虫管理或到与要求控制的庄稼联系的害虫的套房。相反焦点经常在单个害虫种类和他们的生来的敌人的模型系统上。我们建议从生来的敌人捕获害虫控制的管理行动可能向前正在来如果:(i) 害虫建筑群和特定的管理行动上的反应和预言者变量焦点的套房;(ii )“the landscape” 的贡献被估计预定和生来的敌人移民并且移民到并且从目标庄稼,以及害虫的数字识别;并且(iii ) 与庄稼发展阶段排列的害虫控制阀值是基准在害虫上测量生来的敌人的影响,接着允许在学习区域之间的比较,和归纳。为了完成害虫控制,我们将需要合并什么从模型害虫和生来的敌人系统的生态的理解被学习了并且与内场害虫管理集成 areawide 风景管理。 | Nancy A. Schellhorn Hazel R. Parry Sarina Macfadyen Yongmo Wang Myron P. Zalucki | 2015 | Insect Science2015，22，1： | 6 |
| 3 | Assessing the impact of natural enemies in agroecosystems: toward "real" IPM or in quest of the Holy Grail?显示文摘 | Myron P. Zalucki Michael J. Furlong Nancy A. Schellhorn Sarina Macfadyen Andrew P. Davies | 2015 | Insect Science2015，22，1： | 4 |
| 4 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial显示文摘 | Paul M Ridker Aruna Pradhan Jean G MacFadyen Peter Libby Robert J Glynn | 2012 | 2012 (9841)2012，，9841： | 2 |
| 5 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial显示文摘 | Paul M Ridker Aruna Pradhan Jean G MacFadyen Peter Libby Robert J Glynn | 2012 | The Lancet2012，，9841： | 2 |
| 6 | Differences in first dose responseto angiotension coventing enzyme inhibition in congestive heart failure:a placebo controlled study显示文摘 | Lees KR Reid JL | 1991 | Br Heart J1991，66，： | 1 |
| 7 | Bile duct injury after laparoscopic cholecystectomy:the United States experience显示文摘 | MacFadyen BV Vecchio R Ricardo AE | | 0，，： | 1 |
| 8 | High - sensitivity C - reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the Jupiter trial 显示文摘 | Pena JM Macfadyen J Glynn RJ | 2012 | Eur Heart J2012，33，4： | 1 |
| 9 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention:an analysis from the JUPITER trial显示文摘 | RIDKER P M PRADHAN A MACFADYEN J G | 2012 | Lancet2012，380，： | 1 |
| 10 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention : an analysis from the JUPITER trial 显示文摘 | Ridker PM Pradhan A MacFadyen JG etal | 2012 | Lancet2012，380，9841： | 1 |
| 11 | A day in the life of an advertising man: review of internal documents from the UK tobacco industry's principle advertising agencies 显示文摘 | Hasting G MacFadyen L | 2000 | Journal of British Medicine2000，321，： | 1 |
| 12 | How often are angiotensin Ⅱ and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure显示文摘 | MACFADYEN R J LEE A F MORTON J J et al | 1999 | Heart1999，82，1： | 1 |
| 13 | Differing early blood pressure and rennin-angiotensin system responses to the first dose of ACE inhibitors in congestive heart failure显示文摘 | Squire IB MacFadyen RT Reid JL | 1996 | J Cardiovasc Pharmacol1996，27，： | 1 |
| 14 | Laparoscopic common bile duct exploration显示文摘 | Vecchio R MacFadyen B V | 2002 | Langenbecks Arch Surg2002，387，1： | 1 |
| 15 | Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein : a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial显示文摘 | Ridker PM MacFadyen J Cressman M | 2010 | JAm Coll Cardiol2010，55，12： | 1 |
| 16 | Fiber-optic systems for dynamic light scattering a review 显示文摘 | Macfadyen A J Jennings B R | 1990 | Optics & Laster Technology1990，22，3： | 1 |
| 17 | Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes : effect of 1 year's cardiovascular risk reduction therapy 显示文摘 | Tayebjee MH Lira HS Macfadyen RJ | 2004 | Diabetes Care2004，27，8： | 1 |
| 18 | High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibril- lation: an exploratory analysis of the JUPITER trial 显示文摘 | Pena JM MacFadyen J Glynn RJ | 2012 | Eur Heart J2012，33，4： | 1 |
| 19 | Num- ber needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low - density lipoprotein cholesterol and elevated high - sensitivity C - reactive protein: justification for the use of statins in prevention: an inter- vention trial evaluating rosuvastatin(JUPITER) 显示文摘 | RIDKER P M MACFADYEN J G FONSECA F A | 2009 | Circ Cardio- vasc Qual Outcomes2009，2，6： | 1 |
| 20 | High- sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial 显示文摘 | PENA J M MACFADYEN J GLYNN R J | 2012 | Eur heart J2012，33，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员